PP 1.10 – 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir

• J. Howard,
• C. Levinger,
• W. Wang,
• H. Takata,
• S. Nathanson,
• R. Fromentin,
• N. Chomont,
• L. Trautmann,
• A. Bosque

Affiliations

J. Howard

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, USA

C. Levinger

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, USA

W. Wang

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, USA

H. Takata

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA

S. Nathanson

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA

R. Fromentin

Université de Montréal, Centre de recherche du CHUM, Montréal, Canada

N. Chomont

Université de Montréal, Centre de recherche du CHUM, Montréal, Canada

L. Trautmann

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA

A. Bosque

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, USA